Moran Wealth Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Moran Wealth Management’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.45M	Buy	58,215 +9,011	+18%	+$287K	0.07%	296
2026 Q1	$1.3M	Buy	49,204 +21,811	+80%	+$639K	0.04%	341
2025 Q4	$794K	Buy	27,393 +4,747	+21%	+$142K	0.02%	370
2025 Q3	$629K	Buy	22,646 +9,855	+77%	+$249K	0.02%	382
2025 Q2	$311K	Buy	+12,791	New	+$280K	0.01%	451

Other funds holding ARKG

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Moran Wealth Management's ARKG Position: Q2 2026 in Review

Moran Wealth Management increased its ARK Genomic Revolution ETF (ARKG) stake by 18% in Q2 2026, buying an estimated $287K and bringing the position to 58,215 shares worth $2.45M. The position accounts for 0.07% of the portfolio, ranked #296.

Moran Wealth Management first reported a position in ARKG in Q2 2025 and has held it in 5 quarters since. 272 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

Moran Wealth Management held 58,215 shares of ARK Genomic Revolution ETF worth $2.45M as of Q2 2026.
Moran Wealth Management bought 9,011 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $287K.
ARK Genomic Revolution ETF made up 0.07% of Moran Wealth Management's portfolio in Q2 2026, its #296 holding.
Moran Wealth Management first reported a position in ARK Genomic Revolution ETF in Q2 2025 and has held it in 5 quarters since.
272 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Moran Wealth Management's 13F filing for Q2 2026, filed 5 Aug 2026.